Wed, April 15, 2009
Tue, April 14, 2009
Mon, April 13, 2009
Fri, April 10, 2009
Thu, April 9, 2009
Wed, April 8, 2009
Tue, April 7, 2009
Mon, April 6, 2009
Fri, April 3, 2009
Thu, April 2, 2009
Wed, April 1, 2009
Tue, March 31, 2009
Mon, March 30, 2009
Fri, March 27, 2009
Thu, March 26, 2009
Wed, March 25, 2009
Tue, March 24, 2009
Mon, March 23, 2009
Fri, March 20, 2009
Thu, March 19, 2009
Wed, March 18, 2009
Tue, March 17, 2009
Mon, March 16, 2009
Sun, March 15, 2009
Fri, March 13, 2009
Thu, March 12, 2009
Wed, March 11, 2009
Tue, March 10, 2009
Mon, March 9, 2009
Fri, March 6, 2009
Thu, March 5, 2009
Wed, March 4, 2009
Tue, March 3, 2009
Mon, March 2, 2009
Fri, February 27, 2009
Thu, February 26, 2009
Wed, February 25, 2009
Tue, February 24, 2009
Mon, February 23, 2009

Eurand N.V.: Eurand to Present at Cowen Health Care Conference


//health-fitness.news-articles.net/content/2009/ .. -to-present-at-cowen-health-care-conference.html
Published in Health and Fitness on Wednesday, March 4th 2009 at 6:13 GMT, Last Modified on 2009-03-04 06:14:24 by Market Wire   Print publication without navigation


PHILADELPHIA, PA--(Marketwire - March 4, 2009) - Eurand N.V. (NASDAQ: [ EURX ]), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced today that it is scheduled to present at the upcoming Cowen Health Care Conference. John Fraher, Eurand's Chief Commercial Officer, will be presenting.

 Event: Cowen Health Care Conference Date: Wednesday, March 18, 2009 Time: 11:00 a.m. ET Location: Boston Marriott Copley Place Hotel, Boston, Mass. 

An audio webcast of the presentation will be available by accessing the investor relations section of Eurand's web site at [ www.eurand.com ]. A replay of the presentation will be available until April 18, 2009.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. Eurand has had four products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking orally disintegrating tablet (ODT) formulations, and drug conjugation.

Eurand is a global company with facilities in the U.S. and Europe. For more information, visit Eurand's website at [ www.eurand.com ].


Publication Contributing Sources

Similar Health and Fitness Publications